Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,121.54
    +7.19 (+0.34%)
     
  • Crude Oil

    83.03
    +1.68 (+2.07%)
     
  • Gold

    2,241.20
    +28.50 (+1.29%)
     
  • Silver

    25.00
    +0.24 (+0.98%)
     
  • EUR/USD

    1.0791
    -0.0039 (-0.36%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2622
    -0.0016 (-0.13%)
     
  • USD/JPY

    151.3810
    +0.1350 (+0.09%)
     
  • Bitcoin USD

    70,852.96
    +2,115.47 (+3.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Aspen Aerogels Third Quarter 2022 Earnings: Misses Expectations

Aspen Aerogels (NYSE:ASPN) Third Quarter 2022 Results

Key Financial Results

  • Revenue: US$36.7m (up 21% from 3Q 2021).

  • Net loss: US$29.6m (loss widened by 278% from 3Q 2021).

  • US$0.75 loss per share (further deteriorated from US$0.24 loss in 3Q 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aspen Aerogels Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 27%. Earnings per share (EPS) also missed analyst estimates by 31%.

Looking ahead, revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in the US.

Performance of the American Chemicals industry.

The company's shares are down 2.4% from a week ago.

Risk Analysis

Be aware that Aspen Aerogels is showing 3 warning signs in our investment analysis and 1 of those can't be ignored...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

Advertisement